ITPKB and Parkinson disease: In addition, when we distributed ITPKB mRNA quantified in the PD patients into quartiles, based on SNCA expression in the control group, we see statistically significant differences at α = 0.1 comparing cases and controls falling into the highest quartile, suggesting the overall SNCA mRNA expression is higher in PD brains (Figure 5B).